The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
Author:
Affiliation:
1. Department of Pharmaceutical and Pharmacological Sciences KU Leuven Leuven Belgium
2. Medicines Evaluation Board (MEB) Agency Utrecht The Netherlands
3. Hospital Pharmacy Erasmus University Medical Center Rotterdam The Netherlands
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1836
Reference88 articles.
1. European Medicines Agency.Guideline on similar biological medicinal products.2014.
2. European Medicines Agency.Medicines ‐ Centrally authorised biosimilar medicines. Accessed July 21 2019.
3. The US Food and Drug Administration.Biosimilar Product Information ‐ FDA Approved Biosimilar Products. Accessed July 21 2019.
4. IMS Institute for Healthcare Informatics.Delivering on the Potential of Biosimilar Medicines: The Role of Functioning Competitive Markets(2016).
5. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Self-Assembly of Silole-Based Aggregation-Induced Emission Compounds with Green Fluorescent Protein under Physiological Conditions for Traceable and Versatile Drug Delivery;ACS Applied Bio Materials;2024-09-10
2. Safety of Rituximab biosimilar (Riximyo®) following a single switch from the reference product in patients with Non-Hodgkin’s lymphoma: a retrospective study;Annals of Hematology;2024-09-09
3. Enhancing Monoclonal Antibodies with Natural Products: Mechanisms and Applications;Intelligent Pharmacy;2024-09
4. Les enjeux de la substitution des biosimilaires comparée à celle des génériques et des hybrides;Médecine & Droit;2024-08
5. Monoclonal antibody biosimilars for cancer treatment;iScience;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3